Remy WIDEHEM
Nîmes, Gard, 30029, France
NCT Number: NCT05825560
ICU patients experience moderate to severe pain. Studies and guidelines point out the benefits of multimodal analgesia on pain control, opioid spare and on lowering its adverse effects. However, no recommendation about drugs or protocol has been formulated. In our study, investigators studied the feasibility and the impact on Remifentanil spare of a standardized protocol using multimodal analgesia (Paracetamol, Nefopam, Tramadol, Ketamine, Remifentanil) compared to the standard-of-care strategy using Paracetamol and Remifentanil. The investigators conducted a prospective, ''proof of concept'', randomized, double-blind, parallel group, placebo-controlled trial. The investigators studied multimodal analgesia versus standard-of-care in ICU patients requiring sedation-analgesia for invasive mechanical ventilation.The investigators hypothesized that Remifentanil consumption decrease by 15% with the use of a standardized multimodal analgesia strategy
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Nîmes, Gard, 30029, France
ICU patients requiring sedation-analgesia for mechanical ventilation for at least 48 hours are randomized in 2 parallel groups : control arm using ''standard of care'' analgesia (Paracetamol and Remifentanil), and interventional arm using multimodal analgesia at different level according to pain accessed by BPS (Step 1 : Paracetamol, Nefopam, Tramadol, Step 2 : Ketamine, Step 3 : Remifentanil). Sedation drugs are standard of care (Propofol and Midazolam if Propofol isn't enough) to obtain prescribed sedation accessed by RASS. Double-bling is kept for 72 hours until the primary outcome is obtained.
The investigators hypothesize a 15% reduction of Remifentanil consumption in the interventional group.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Multimodal opioid free analgesia
Standard remifentanil analgesia
Time frame: 48th hour after randomisation
daily consumption of remifentanil between the 24th hour and the 48th hour after randomisation of patients admitted to the ICU and requiring at least 48 hours of mechanical ventilation
Time frame: Day 28
Cumulative dose of remifentanil
Time frame: Day 28
Number of lived days free of remifentanil
Time frame: Day 28
Daily consumption of sedative drugs from inclusion to D28
Time frame: Day 28
Number of live days free of mechanical ventilation
Time frame: Day 28
Number of lived days free of norepinephrine
Time frame: Day 28
SOFA Score (Sepsis-related Organ Failure Assessment)
Time frame: Day 28
Daily fuid intake in milliliter
Time frame: Day 28
CAM ICU test
Time frame: Day 28
Presence of one or more events of special interest or expected adverse events: constipation, bradycardia, bladder globe, nausea, vomiting, liver disturbance, serotonin syndrome
Time frame: Day 28
Presence of pneumonia associated with mechanical ventilation
Time frame: 48 hours after extubation
extubation failure and cause (reintubation within 48 hours of first extubation)
Time frame: Day 90
Length of stay in the intensive care unit and in the hospital
Time frame: Day 90
Vital status at day 28 and day 90
Time frame: Day 90
Opioid use at D90
Centre Hospitalier Universitaire de Nīmes
Other
Opioid-free Analgesia in Intensive Care Unit: a Prospective, Monocentric, Randomized, Double Blind, Feasability Clinical Trial
Acronym: OFICU
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07730918
Hemodynamic Instability During Anesthesia, Induction Anesthesia
Zhangjiagang, Jiangsu, China
View Trial DetailsNCT05719194
Intubation, Mechanical Ventilation
Bordeaux, France
View Trial DetailsNCT07125495
Infection, Infections
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT04782817
Cardiovascular Surgical Procedure, Intubation
Nashville, Tennessee, United States
View Trial Details